BVBiomedical Ltd.

BVBiomedical is a U.K. biotech company located at the Oxford Science Park, Oxford, UK. It is developing Lynflexine™, a first-in-class drug candidate with disease modifying potential for the treatment of relapsing remitting and progressive forms of multiple sclerosis and for the treatment of neurode... Read more